{"transactions":[{"id":745067,"issuer":{"id":2359,"kind":"organization","name":"Pulmonx Corp","symbol":"LUNG"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-09T21:49:44.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of Restricted Stock Units (\"RSU Grant\") payable solely in common stock of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant of June 5, 2026, or if such date is not a business day, then on the next business day, or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent to the date such RSU Grant is made."}],"balance_after":139714,"source":{"system":"sec-edgar","filing":"0001222358-26-000002","document":"form4-06092026_090640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1127537/000122235826000002/form4-06092026_090640.xml","form_type":"4"}},{"id":784699,"issuer":{"id":5669,"kind":"organization","name":"Mobia Medical, Inc.","symbol":"MOBI"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-05-12T01:36:32.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":31520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in three substantially equal installments on the first three anniversaries of the grant date."}],"balance_after":31520,"derivative":{"exercise_price":15,"expiration_date":"2036-05-07","underlying":"Common Stock","underlying_shares":31520},"source":{"system":"sec-edgar","filing":"0001628280-26-033807","document":"wk-form4_1778549790.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1489993/000162828026033807/wk-form4_1778549790.xml","form_type":"4"}},{"id":784698,"issuer":{"id":5669,"kind":"organization","name":"Mobia Medical, Inc.","symbol":"MOBI"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T01:36:32.000Z","date":"2026-05-11","kind":"purchase","planned":false,"acquired":true,"shares":7000,"price":15,"value":105000.0,"ownership":{"direct":true},"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001628280-26-033807","document":"wk-form4_1778549790.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489993/000162828026033807/wk-form4_1778549790.xml","form_type":"4"}},{"id":793819,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T22:27:03.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":3562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued service with the Issuer through the applicable vesting date."}],"balance_after":26213,"source":{"system":"sec-edgar","filing":"0001104659-26-055065","document":"tm2613528-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465926055065/tm2613528-7_4seq1.xml","form_type":"4"}},{"id":1123326,"issuer":{"id":2359,"kind":"organization","name":"Pulmonx Corp","symbol":"LUNG"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-04T21:58:28.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":37153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of Restricted Stock Units (\"RSU Grant\") payable solely in common stock of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant of June 2, 2025, or if such date is not a business day, then on the next business day, or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent to the date such RSU Grant is made."}],"balance_after":99714,"source":{"system":"sec-edgar","filing":"0001415889-25-015636","document":"form4-06042025_090625.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1127537/000141588925015636/form4-06042025_090625.xml","form_type":"4"}},{"id":1159156,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-05T23:25:40.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":1266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date."}],"balance_after":22651,"source":{"system":"sec-edgar","filing":"0001104659-25-044667","document":"tm2514079-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465925044667/tm2514079-2_4seq1.xml","form_type":"4"}},{"id":1259222,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-02-20T01:05:29.000Z","date":"2025-02-19","kind":"other","planned":false,"acquired":false,"shares":11148,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated January 6, 2025, by and among Stryker Corporation (\"Parent\"), Eagle 1 Merger Sub, Inc. (\"Merger Sub\"), and Inari Medical, Inc. (\"Issuer\") on February 19, 2025 (the \"Effective Time\"), Merger Sub merged with and into Issuer, with Issuer surviving as a wholly owned subsidiary of Parent upon consummation of the transactions contemplated by the Merger Agreement. At the Effective Time, each outstanding share of common stock of the Issuer (\"Common Stock\") was cancelled and converted into the right to receive $80.00 in cash (the \"Merger Consideration\"), without interest."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 4,126 restricted stock units (\"RSUs\"). At the Effective Time, each outstanding award of RSUs was canceled and converted into the right to receive an amount in cash equal to the product of the aggregate number of shares of Common Stock underlying such RSU immediately prior to the Effective Time, multiplied by the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated January 6, 2025, by and among Stryker Corporation (\"Parent\"), Eagle 1 Merger Sub, Inc. (\"Merger Sub\"), and Inari Medical, Inc. (\"Issuer\") on February 19, 2025 (the \"Effective Time\"), Merger Sub merged with and into Issuer, with Issuer surviving as a wholly owned subsidiary of Parent upon consummation of the transactions contemplated by the Merger Agreement. At the Effective Time, each outstanding share of common stock of the Issuer (\"Common Stock\") was cancelled and converted into the right to receive $80.00 in cash (the \"Merger Consideration\"), without interest."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-25-005740","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1222358/000112760225005740/form4.xml","form_type":"4"}},{"id":1490494,"issuer":{"id":2359,"kind":"organization","name":"Pulmonx Corp","symbol":"LUNG"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-05T21:51:59.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":15216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of Restricted Stock Units (\"RSU Grant\") payable solely in common stock of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant of June 3, 2024, or if such date is not a business day, then on the next business day, or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent to the date such RSU Grant is made."}],"balance_after":62561,"source":{"system":"sec-edgar","filing":"0001415889-24-015625","document":"form4-06052024_090656.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1127537/000141588924015625/form4-06052024_090656.xml","form_type":"4"}},{"id":1496426,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-31T20:49:29.000Z","date":"2024-04-24","kind":"grant","planned":false,"acquired":true,"shares":4126,"price":42.41,"value":174983.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted on April 24, 2024 to the Reporting Person that vest in full on the earlier of (1) the day prior to the Issuer's next annual meeting of stockholders or (2) one year from the date of grant."}],"balance_after":11148,"source":{"system":"sec-edgar","filing":"0001127602-24-017127","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1222358/000112760224017127/form4a.xml","form_type":"4/A","original_submission_date":"2024-04-26"}},{"id":1526321,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-06T22:16:54.000Z","date":"2024-05-02","kind":"grant","planned":false,"acquired":true,"shares":716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date."}],"balance_after":21385,"source":{"system":"sec-edgar","filing":"0001104659-24-057570","document":"tm2413647-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465924057570/tm2413647-5_4seq1.xml","form_type":"4"}},{"id":1534641,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-26T20:52:30.000Z","date":"2024-04-24","kind":"grant","planned":false,"acquired":true,"shares":4126,"price":42.41,"value":174983.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted on April 24, 2024 to the Reporting Person that vest in full on the earlier of (1) the day prior to the Issuer's next annual meeting of stockholders or (2) one year from the date of grant."}],"balance_after":11148,"source":{"system":"sec-edgar","filing":"0001127602-24-013472","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1222358/000112760224013472/form4.xml","form_type":"4"}},{"id":1870528,"issuer":{"id":2359,"kind":"organization","name":"Pulmonx Corp","symbol":"LUNG"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T22:24:06.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":12620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of Restricted Stock Units (\"RSU Grant\") payable solely in common stock of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant of June 1, 2023, or if such date is not a business day, then on the next business day, or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent to the date such RSU Grant is made."}],"balance_after":47345,"source":{"system":"sec-edgar","filing":"0001209191-23-033981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1127537/000120919123033981/doc4.xml","form_type":"4"}},{"id":1884281,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-19T22:14:25.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":2412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents RSUs granted on May 18, 2023, to the Reporting Person that vest in full on the earlier to occur of (i) the one-year anniversary of the grant date and (ii) the date of the 2024 annual meeting."}],"balance_after":7022,"source":{"system":"sec-edgar","filing":"0001127602-23-016360","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1222358/000112760223016360/form4.xml","form_type":"4"}},{"id":1910134,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-01T23:53:19.000Z","date":"2023-04-27","kind":"grant","planned":false,"acquired":true,"shares":669,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date."}],"balance_after":20669,"source":{"system":"sec-edgar","filing":"0001104659-23-054655","document":"tm2314266-10_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465923054655/tm2314266-10_4seq1.xml","form_type":"4"}},{"id":2245460,"issuer":{"id":2359,"kind":"organization","name":"Pulmonx Corp","symbol":"LUNG"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T22:14:03.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":5600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of Restricted Stock Units (\"RSU Grant\") payable solely in common stock of the Issuer that vest on the earlier of (i) the one-year anniversary of the date of grant of June 1, 2022, or (ii) the date of the Annual Meeting of the Stockholders for the year subsequent to the date such RSU Grant is made."}],"balance_after":34725,"source":{"system":"sec-edgar","filing":"0001209191-22-034321","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1127537/000120919122034321/doc4.xml","form_type":"4"}},{"id":2253009,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-27T20:35:40.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":2420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents RSUs granted on May 26, 2022, to the Reporting Person that vest in full on the earlier to occur of (i) the one-year anniversary of the grant date and (ii) the date of the 2023 annual meeting."}],"balance_after":4610,"source":{"system":"sec-edgar","filing":"0001127602-22-015873","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1222358/000112760222015873/form4.xml","form_type":"4"}},{"id":2270036,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2022-05-16T18:34:37.000Z","date":"2022-05-13","kind":"other","acquired":false,"shares":6035,"price":28.25,"value":170488.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."}],"balance_after":0,"derivative":{"exercise_price":26.05,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":6035},"source":{"system":"sec-edgar","filing":"0001562180-22-004067","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218022004067/primarydocument.xml","form_type":"4"}},{"id":2270035,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2022-05-16T18:34:37.000Z","date":"2022-05-13","kind":"other","acquired":false,"shares":12500,"price":28.25,"value":353125.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."}],"balance_after":0,"derivative":{"exercise_price":27.45,"expiration_date":"2025-06-03","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001562180-22-004067","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218022004067/primarydocument.xml","form_type":"4"}},{"id":2270034,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2022-05-16T18:34:37.000Z","date":"2022-05-13","kind":"other","acquired":false,"shares":3473,"price":28.25,"value":98112.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."}],"balance_after":0,"derivative":{"exercise_price":42.05,"expiration_date":"2028-06-04","underlying":"Common Stock","underlying_shares":3473},"source":{"system":"sec-edgar","filing":"0001562180-22-004067","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218022004067/primarydocument.xml","form_type":"4"}},{"id":2270033,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-16T18:34:37.000Z","date":"2022-05-13","kind":"other","acquired":false,"shares":9666,"price":28.25,"value":273064.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."}],"balance_after":0,"derivative":{"exercise_price":11.84,"expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":9666},"source":{"system":"sec-edgar","filing":"0001562180-22-004067","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218022004067/primarydocument.xml","form_type":"4"}},{"id":2270032,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-16T18:34:37.000Z","date":"2022-05-13","kind":"other","acquired":false,"shares":12500,"price":28.25,"value":353125.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."}],"balance_after":0,"derivative":{"exercise_price":13.79,"expiration_date":"2026-06-01","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001562180-22-004067","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218022004067/primarydocument.xml","form_type":"4"}},{"id":2270031,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-16T18:34:37.000Z","date":"2022-05-13","kind":"other","acquired":false,"shares":5734,"price":28.25,"value":161985.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."}],"balance_after":0,"derivative":{"exercise_price":16.5,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":5734},"source":{"system":"sec-edgar","filing":"0001562180-22-004067","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218022004067/primarydocument.xml","form_type":"4"}},{"id":2270030,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-16T18:34:37.000Z","date":"2022-05-13","kind":"other","acquired":false,"shares":12500,"price":28.25,"value":353125.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."}],"balance_after":0,"derivative":{"exercise_price":16.53,"expiration_date":"2024-09-04","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001562180-22-004067","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218022004067/primarydocument.xml","form_type":"4"}},{"id":2270029,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-16T18:34:37.000Z","date":"2022-05-13","kind":"other","acquired":false,"shares":5172,"price":28.25,"value":146109.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes."}],"balance_after":0,"derivative":{"exercise_price":23.02,"expiration_date":"2029-06-03","underlying":"Common Stock","underlying_shares":5172},"source":{"system":"sec-edgar","filing":"0001562180-22-004067","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218022004067/primarydocument.xml","form_type":"4"}},{"id":2270028,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-16T18:34:37.000Z","date":"2022-05-13","kind":"other","acquired":false,"shares":3239,"price":28.25,"value":91501.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit that was subject to vesting conditions based solely on continued employment with or service to the Company or any of its subsidiaries (each, an 'Issuer RSU') that was outstanding and unvested immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer RSU and (2) the Common Stock Merger Consideration, subject to any required withholding of taxes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit that was subject to vesting conditions based solely on continued employment with or service to the Company or any of its subsidiaries (each, an 'Issuer RSU') that was outstanding and unvested immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer RSU and (2) the Common Stock Merger Consideration, subject to any required withholding of taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-22-004067","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218022004067/primarydocument.xml","form_type":"4"}},{"id":2270027,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-16T18:34:37.000Z","date":"2022-05-13","kind":"other","acquired":false,"shares":20890,"price":28.25,"value":590142.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects disposition of Issuer common stock in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger (the 'Merger Agreement'), dated August 6, 2021, by and among the Issuer, Medtronic, Inc. ('Parent') and Project Kraken Merger Sub, Inc., a wholly-owned subsidiary of Parent ('Merger Sub'), including the consummation of the merger (the 'Merger') between Issuer and Merger Sub on May 13, 2022. Pursuant to the Merger Agreement, as of the effective time of the Merger (the 'Effective Time'), [each outstanding share of Issuer common stock, $0.001 par value per share ('Issuer Common Stock'), was cancelled, retired and converted into the right to receive an amount equal to $28.25 in cash, without interest thereon (the 'Common Stock Merger Consideration'), subject to any required withholding of taxes]."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition of Issuer common stock in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger (the 'Merger Agreement'), dated August 6, 2021, by and among the Issuer, Medtronic, Inc. ('Parent') and Project Kraken Merger Sub, Inc., a wholly-owned subsidiary of Parent ('Merger Sub'), including the consummation of the merger (the 'Merger') between Issuer and Merger Sub on May 13, 2022. Pursuant to the Merger Agreement, as of the effective time of the Merger (the 'Effective Time'), [each outstanding share of Issuer common stock, $0.001 par value per share ('Issuer Common Stock'), was cancelled, retired and converted into the right to receive an amount equal to $28.25 in cash, without interest thereon (the 'Common Stock Merger Consideration'), subject to any required withholding of taxes]."}],"balance_after":3239,"source":{"system":"sec-edgar","filing":"0001562180-22-004067","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218022004067/primarydocument.xml","form_type":"4"}},{"id":2276166,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-11T00:44:59.000Z","date":"2022-04-28","kind":"grant","acquired":true,"shares":1243,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on April 28, 2023, subject to the Reporting Person's continuous service to the Issuer through such date."}],"balance_after":1243,"derivative":{"exercise_price":211.29,"expiration_date":"2032-04-28","underlying":"Common Stock","underlying_shares":1243},"source":{"system":"sec-edgar","filing":"0001104659-22-058413","document":"tm2215111d1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465922058413/tm2215111d1_4seq1.xml","form_type":"4"}},{"id":2548440,"issuer":{"id":83035,"kind":"organization","name":"Inari Medical, Inc.","symbol":"NARI"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-05T21:59:16.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":2190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that vests 1/3 on each of the first, second and third anniversary of the grant date."}],"balance_after":2190,"source":{"system":"sec-edgar","filing":"0001562180-21-006321","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1222358/000156218021006321/primarydocument.xml","form_type":"4"}},{"id":2672403,"issuer":{"id":2359,"kind":"organization","name":"Pulmonx Corp","symbol":"LUNG"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-12T00:18:18.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":2810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that will vest on the one-year anniversary of the date of grant of June 1, 2021."}],"balance_after":29125,"source":{"system":"sec-edgar","filing":"0001209191-21-040072","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1127537/000120919121040072/doc4.xml","form_type":"4"}},{"id":2679070,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-07T21:34:06.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":5734,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest in 12 equal monthly installments commencing on June 3, 2021."}],"balance_after":5734,"derivative":{"exercise_price":16.5,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":5734},"source":{"system":"sec-edgar","filing":"0001562180-21-004116","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218021004116/primarydocument.xml","form_type":"4"}},{"id":2679069,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-07T21:34:06.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":3239,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest one year from grant date on June 3, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,239 restricted stock units."}],"balance_after":24129,"source":{"system":"sec-edgar","filing":"0001562180-21-004116","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218021004116/primarydocument.xml","form_type":"4"}},{"id":2732991,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-03T21:10:49.000Z","date":"2021-04-29","kind":"grant","acquired":true,"shares":1175,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on April 29, 2022, subject to the Reporting Person's continuous service to the Issuer through such date."}],"balance_after":1175,"derivative":{"exercise_price":240.68,"expiration_date":"2031-04-29","underlying":"Common Stock","underlying_shares":1175},"source":{"system":"sec-edgar","filing":"0001104659-21-060305","document":"tm2114992-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465921060305/tm2114992-2_4seq1.xml","form_type":"4"}},{"id":3013775,"issuer":{"id":2359,"kind":"organization","name":"Pulmonx Corp","symbol":"LUNG"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series E-1 Preferred Stock","published_at":"2020-10-05T20:16:14.000Z","date":"2020-10-05","kind":"exercise","acquired":false,"shares":87475,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by Kleiner Perkins Caufield & Byers XIII, LLC (\"KPCB XIII\"). All shares are held for convenience in the name of \"KPCB Holdings, Inc., as nominee\". The managing member of KPCB XIII is KPCB XIII Associates, LLC (\"XIII Associates\"). The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 102,725 shares of Common Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of \"KPCB Holdings, Inc. as nominee,\" for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":87475},"source":{"system":"sec-edgar","filing":"0001628280-20-014283","document":"wf-form4_160192892933103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1127537/000162828020014283/wf-form4_160192892933103.xml","form_type":"4"}},{"id":3013774,"issuer":{"id":2359,"kind":"organization","name":"Pulmonx Corp","symbol":"LUNG"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series D-1 Preferred Stock","published_at":"2020-10-05T20:16:14.000Z","date":"2020-10-05","kind":"exercise","acquired":false,"shares":168223,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by Kleiner Perkins Caufield & Byers XIII, LLC (\"KPCB XIII\"). All shares are held for convenience in the name of \"KPCB Holdings, Inc., as nominee\". The managing member of KPCB XIII is KPCB XIII Associates, LLC (\"XIII Associates\"). The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 102,725 shares of Common Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of \"KPCB Holdings, Inc. as nominee,\" for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":168223},"source":{"system":"sec-edgar","filing":"0001628280-20-014283","document":"wf-form4_160192892933103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1127537/000162828020014283/wf-form4_160192892933103.xml","form_type":"4"}},{"id":3013773,"issuer":{"id":2359,"kind":"organization","name":"Pulmonx Corp","symbol":"LUNG"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C-1 Preferred Stock","published_at":"2020-10-05T20:16:14.000Z","date":"2020-10-05","kind":"exercise","acquired":false,"shares":1268411,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by Kleiner Perkins Caufield & Byers XIII, LLC (\"KPCB XIII\"). All shares are held for convenience in the name of \"KPCB Holdings, Inc., as nominee\". The managing member of KPCB XIII is KPCB XIII Associates, LLC (\"XIII Associates\"). The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 102,725 shares of Common Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of \"KPCB Holdings, Inc. as nominee,\" for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1268411},"source":{"system":"sec-edgar","filing":"0001628280-20-014283","document":"wf-form4_160192892933103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1127537/000162828020014283/wf-form4_160192892933103.xml","form_type":"4"}},{"id":3013772,"issuer":{"id":2359,"kind":"organization","name":"Pulmonx Corp","symbol":"LUNG"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-05T20:16:14.000Z","date":"2020-10-05","kind":"purchase","acquired":true,"shares":26315,"price":19,"value":499985.0,"ownership":{"direct":true},"balance_after":26315,"source":{"system":"sec-edgar","filing":"0001628280-20-014283","document":"wf-form4_160192892933103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1127537/000162828020014283/wf-form4_160192892933103.xml","form_type":"4"}},{"id":3013771,"issuer":{"id":2359,"kind":"organization","name":"Pulmonx Corp","symbol":"LUNG"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-05T20:16:14.000Z","date":"2020-10-05","kind":"exercise","acquired":true,"shares":87475,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by Kleiner Perkins Caufield & Byers XIII, LLC (\"KPCB XIII\"). All shares are held for convenience in the name of \"KPCB Holdings, Inc., as nominee\". The managing member of KPCB XIII is KPCB XIII Associates, LLC (\"XIII Associates\"). The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 102,725 shares of Common Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of \"KPCB Holdings, Inc. as nominee,\" for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":1524109,"source":{"system":"sec-edgar","filing":"0001628280-20-014283","document":"wf-form4_160192892933103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1127537/000162828020014283/wf-form4_160192892933103.xml","form_type":"4"}},{"id":3013770,"issuer":{"id":2359,"kind":"organization","name":"Pulmonx Corp","symbol":"LUNG"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-05T20:16:14.000Z","date":"2020-10-05","kind":"exercise","acquired":true,"shares":168223,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by Kleiner Perkins Caufield & Byers XIII, LLC (\"KPCB XIII\"). All shares are held for convenience in the name of \"KPCB Holdings, Inc., as nominee\". The managing member of KPCB XIII is KPCB XIII Associates, LLC (\"XIII Associates\"). The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 102,725 shares of Common Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of \"KPCB Holdings, Inc. as nominee,\" for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":1436634,"source":{"system":"sec-edgar","filing":"0001628280-20-014283","document":"wf-form4_160192892933103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1127537/000162828020014283/wf-form4_160192892933103.xml","form_type":"4"}},{"id":3013769,"issuer":{"id":2359,"kind":"organization","name":"Pulmonx Corp","symbol":"LUNG"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-05T20:16:14.000Z","date":"2020-10-05","kind":"exercise","acquired":true,"shares":1268411,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's preferred stock automatically converted into an equal number of shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are directly held by Kleiner Perkins Caufield & Byers XIII, LLC (\"KPCB XIII\"). All shares are held for convenience in the name of \"KPCB Holdings, Inc., as nominee\". The managing member of KPCB XIII is KPCB XIII Associates, LLC (\"XIII Associates\"). The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 102,725 shares of Common Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of \"KPCB Holdings, Inc. as nominee,\" for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":1268411,"source":{"system":"sec-edgar","filing":"0001628280-20-014283","document":"wf-form4_160192892933103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1127537/000162828020014283/wf-form4_160192892933103.xml","form_type":"4"}},{"id":3016704,"issuer":{"id":2359,"kind":"organization","name":"Pulmonx Corp","symbol":"LUNG"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-10-02T20:13:09.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 36 equal consecutive monthly installments commencing on September 30, 2020, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":19,"expiration_date":"2030-09-29","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001628280-20-014200","document":"wf-form4_160166957516690.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1127537/000162828020014200/wf-form4_160166957516690.xml","form_type":"4"}},{"id":3118428,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-08T16:53:31.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":9666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest in 12 equal monthly installments commencing on June 4, 2020."}],"balance_after":9666,"derivative":{"exercise_price":11.84,"expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":9666},"source":{"system":"sec-edgar","filing":"0001562180-20-004320","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218020004320/primarydocument.xml","form_type":"4"}},{"id":3118427,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T16:53:31.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":5011,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest one year from grant date on June 4, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,011 restricted stock units."}],"balance_after":20890,"source":{"system":"sec-edgar","filing":"0001562180-20-004320","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218020004320/primarydocument.xml","form_type":"4"}},{"id":3163658,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-05T00:39:54.000Z","date":"2020-04-30","kind":"grant","acquired":true,"shares":3501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on April 30, 2021, subject to the Reporting Person's continuous service to the Issuer through such date."}],"balance_after":3501,"derivative":{"exercise_price":71.66,"expiration_date":"2030-04-30","underlying":"Common Stock","underlying_shares":3501},"source":{"system":"sec-edgar","filing":"0001104659-20-056422","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465920056422/a4.xml","form_type":"4"}},{"id":3498675,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-06T18:12:13.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":5172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest in 12 equal monthly installments commencing on June 4, 2019."}],"balance_after":5172,"derivative":{"exercise_price":23.02,"expiration_date":"2029-06-03","underlying":"Common Stock","underlying_shares":5172},"source":{"system":"sec-edgar","filing":"0001562180-19-003401","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019003401/primarydocument.xml","form_type":"4"}},{"id":3498674,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-06T18:12:13.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":2312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan.  Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting.  The restricted stock units vest one year from grant date on June 4, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,312 restricted stock units."}],"balance_after":15879,"source":{"system":"sec-edgar","filing":"0001562180-19-003401","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019003401/primarydocument.xml","form_type":"4"}},{"id":3538066,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-06T21:58:50.000Z","date":"2019-05-02","kind":"grant","acquired":true,"shares":4569,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on May 2, 2020, subject to the Reporting Person's continuous service to the Issuer through such date."}],"balance_after":4569,"derivative":{"exercise_price":49.96,"expiration_date":"2029-05-02","underlying":"Common Stock","underlying_shares":4569},"source":{"system":"sec-edgar","filing":"0001104659-19-027216","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465919027216/a4.xml","form_type":"4"}},{"id":3839779,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-17T19:04:56.000Z","date":"2018-08-06","kind":"purchase","acquired":true,"shares":3811,"price":26.2247,"value":99942.3317,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $26.075 to $26.30, inclusive.  The Reporting Person undertakes to provide, upon request, full information regarding the number of shares purchase at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,514 Restricted Stock Units."}],"balance_after":13567,"source":{"system":"sec-edgar","filing":"0001562180-18-003703","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018003703/primarydocument.xml","form_type":"4"}},{"id":3901407,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2018-06-07T17:18:55.000Z","date":"2018-06-05","kind":"grant","acquired":true,"shares":3473,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest in 12 equal monthly installments commencing on June 5, 2018."}],"balance_after":3473,"derivative":{"exercise_price":42.05,"expiration_date":"2028-06-04","underlying":"Common Stock","underlying_shares":3473},"source":{"system":"sec-edgar","filing":"0001562180-18-002915","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018002915/primarydocument.xml","form_type":"4"}},{"id":3901406,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-07T17:18:55.000Z","date":"2018-06-05","kind":"grant","acquired":true,"shares":1514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan.  Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting.  The restricted stock units vest one year from grant date on June 5, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,514 RSUs."}],"balance_after":9756,"source":{"system":"sec-edgar","filing":"0001562180-18-002915","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018002915/primarydocument.xml","form_type":"4"}},{"id":3941017,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-05-10T01:16:56.000Z","date":"2018-05-02","kind":"grant","acquired":true,"shares":17296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on May 2, 2019, subject to the Reporting Person's continuous service to the Issuer through such date.  The option was erroneously included on the Reporting Person's Form 3 filed on May 2, 2018."}],"balance_after":17296,"derivative":{"exercise_price":16,"expiration_date":"2028-05-02","underlying":"Common Stock","underlying_shares":17296},"source":{"system":"sec-edgar","filing":"0001104659-18-031862","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465918031862/a4.xml","form_type":"4"}},{"id":3941016,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-10T01:16:56.000Z","date":"2018-05-07","kind":"purchase","acquired":true,"shares":20000,"price":16,"value":320000.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001104659-18-031862","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465918031862/a4.xml","form_type":"4"}},{"id":4292634,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2017-06-05T19:29:53.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":6035,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest in 12 equal monthly installments commencing on June 1, 2017."}],"balance_after":6035,"derivative":{"exercise_price":26.05,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":6035},"source":{"system":"sec-edgar","filing":"0001562180-17-002202","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218017002202/primarydocument.xml","form_type":"4"}},{"id":4292633,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":40169,"kind":"person","name":"Mead Dana G Jr.","position":1,"cik":"0001222358","reported_name":"Mead Dana G Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-05T19:29:53.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":2546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan.  Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting.  The restricted stock units vest one year from grant date on June 1, 2018."}],"balance_after":8242,"source":{"system":"sec-edgar","filing":"0001562180-17-002202","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218017002202/primarydocument.xml","form_type":"4"}}]}